Tech Company Financing Transactions
Celaid Therapeutics Funding Round
Celaid Therapeutics, based in Tokyo, secured $2.6 million in investment from Shionogi & Co..
Transaction Overview
Company Name
Announced On
10/5/2026
Transaction Type
Venture Equity
Amount
$2,600,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds for manufacturing, safety assessment, clinical development, and regulatory activities to support the IND application and initiation of U.S. clinical trials for CLD-001, as well as to strengthen its proprietary platform for new therapeutic modalities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Entrepreneur Lab., South Clinical Research Bldg., the Univer
Tokyo, 113-8485
Japan
Tokyo, 113-8485
Japan
Phone
Website
Email Address
Not Recorded
Overview
The development of new cell therapies in the fight against leukemia and other blood cancers and genetic disorders. We are working on the development of next-generation cell therapy products that will utilize the unique properties of umbilical cord blood and peripheral blood, by expanding them in large quantities.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nobuyuki Arakawa
Chief Operating Officer
Yusuke Inoue
VP - Bus. Development
Asako Uchiyama
Browse more venture capital transactions:
Prev: 10/5/2026: Fleuret AI venture capital transaction
Next: 10/5/2026: Mal Digital venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs